Portola Pharmaceuticals, Inc. (PTLA): Price and Financial Metrics
PTLA Price/Volume Stats
| Current price | $18.03 | 52-week high | $31.73 |
| Prev. close | $17.99 | 52-week low | $5.31 |
| Day low | $17.99 | Volume | 8,094,400 |
| Day high | $18.07 | Avg. volume | 3,172,176 |
| 50-day MA | $15.97 | Dividend yield | N/A |
| 200-day MA | $18.62 | Market Cap | 1.42B |
PTLA Stock Price Chart Interactive Chart >
Portola Pharmaceuticals, Inc. (PTLA) Company Bio
Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly advance the fields of thrombosis and other hematologic diseases. The company was founded in 2003 and is based in South San Francisco, California.
Latest PTLA News From Around the Web
Below are the latest news stories about Portola Pharmaceuticals Inc that investors may wish to consider to help them evaluate PTLA as an investment opportunity.
Portola Pharmaceuticals Inc (PTLA): Hedge Funds Are Cashing OutAt the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […] |
Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.WILMINGTON, Del., June 17, 2020 -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of. |
SHAREHOLDER ALERT: WeissLaw LLP Reminds QUMU, TCO, PTLA, and WLTW Shareholders About Its Ongoing InvestigationsNEW YORK, June 05, 2020 -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice. |
KLXE, TORC, TERP, and PTLA SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersWILMINGTON, Del., June 04, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: KLX Energy Services Holdings, Inc. (NASDAQ GS: KLXE) regarding possible. |
Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.Franklin Financial Network, Inc. (FSB) |
PTLA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -51.28% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 22.34% |
Continue Researching PTLA
Here are a few links from around the web to help you further your research on Portola Pharmaceuticals Inc's stock as an investment opportunity:Portola Pharmaceuticals Inc (PTLA) Stock Price | Nasdaq
Portola Pharmaceuticals Inc (PTLA) Stock Quote, History and News - Yahoo Finance
Portola Pharmaceuticals Inc (PTLA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...